Journal
BIOMATERIALS
Volume 35, Issue 24, Pages 6595-6602Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2014.04.038
Keywords
Surface coating; Nanoparticles; Camptothecin; Hyperbranched polyglycerol; Polylactic acid
Funding
- NIH [EB000487, CA149128]
- Department of Defense (DOD) [W81XWH-10-1-0295]
- Clinical and Translational Science Award Grant from the National Center for Advancing Translational Sciences [UL1-RR024139]
Ask authors/readers for more resources
A key attribute for nanoparticles (NPs) that are used in medicine is the ability to avoid rapid uptake by phagocytic cells in the liver and other tissues. Poly(ethylene glycol) (PEG) coatings has been the gold standard in this regard for several decades. Here, we examined hyperbranched polyglycerols (HPG) as an alternate coating on NPs. In earlier work, HPG was modified with amines and subsequently conjugated to poly(lactic acid) (PLA), but that approach compromised the ability of HPG to resist non-specific adsorption of biomolecules. Instead, we synthesized a copolymer of PLA HPG by a one-step esterification. NPs were produced from a single emulsion using PLA HPG: fluorescent dye or the anti-tumor agent camptothecin (CPT) were encapsulated at high efficiency in the NPs. PLA HPG NPs were quantitatively compared to PLA PEG NPs, produced using approaches that have been extensively optimized for drug delivery in humans. Despite being similar in size, drug release profile and in vitro cytotoxicity, the PLA-HPG NPs showed significantly longer blood circulation and significantly less liver accumulation than PLA PEG. CPT-loaded PLA HPG NPs showed higher stability in suspension and better therapeutic effectiveness against tumors in vivo than CPT-loaded PLA PEG NPs. Our results suggest that HPG is superior to PEG as a surface coating for NPs in drug delivery. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available